Latest Views & News

100% Vindication for @TomWinnifrith: Shield Therapeutics admits to failed $30m placing, gets bailout loan but will still be bust by Christmas

By Tom Winnifrith, the Sheriff of AIM | Thursday 30 June 2022

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Oh dear, oh dear. This is truly awful, and explains why results normally released in late April, came out today - deadline day. Shield Therapeutics (STX) is in a mess, as I warned so often. Ouzo for me. Cabbage water for those who ignored my explicit warnings and instead, hurled abuse at me.

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £5.99 per month for all articles, the Bearcast, and our seven year archive.

Filed under:

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Tuesday »


Synectics – a recovery Buy?



Malcolm Stacey is Moving House

Monday »


Wood Group - a Buy (again)?



Video: Bubbles always implode